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R E S E A R C H A R T I C L E
11b-HSD1 Modulates the Set Point of Brown Adipose
Tissue Response to Glucocorticoids in Male Mice
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University of Oxford, Churchill Hospital, Headington, OxfordOX3 7LE, United Kingdom; 4Faculty ofMedicine
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Glucocorticoids (GCs) are potent regulators of energy metabolism. Chronic GC exposure suppresses
brownadipose tissue (BAT) thermogenic capacity inmice,with evidence for a similar effect inhumans.
Intracellular GC levels are regulatedby 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) activity,
which can amplify circulating GC concentrations. Therefore, 11b-HSD1 could modulate the impact of
GCs on BAT function. This study investigated how 11b-HSD1 regulates the molecular architecture of
BAT in the context of GC excess and aging. Circulating GC excess was induced in 11b-HSD1 knockout
(KO) and wild-type mice by supplementing drinking water with 100 mg/mL corticosterone, and the
effects on molecular markers of BAT function and mitochondrial activity were assessed. Brown
adipocyte primary cultures were used to examine cell autonomous consequences of 11b-HSD1 de-
ficiency. Molecularmarkers of BAT function were also examined in aged 11b-HSD1 KOmice tomodel
lifetime GC exposure. BAT 11b-HSD1 expression and activity were elevated in response to GC excess
and with aging. 11b-HSD1 KO BAT resisted the suppression of uncoupling protein 1 (UCP1) and
mitochondrial respiratory chain subunit proteins normally imposedbyGCexcess. Furthermore, brown
adipocytes from11b-HSD1KOmice had elevated basalmitochondrial function andwere able to resist
GC-mediated repression of activity. BAT fromaged 11b-HSD1 KOmice showed elevatedUCP1 protein
and mitochondrial content, and a favorable profile of BAT function. These data reveal a novel
mechanism in which increased 11b-HSD1 expression, in the context of GC excess and aging, impairs
the molecular and metabolic function of BAT. (Endocrinology 158: 1964–1976, 2017)
Brown adipose tissue (BAT) is adapted to expendchemical energy in the form of heat, predominantly
through the action of the uncoupling protein 1 (UCP1),
and has important roles in whole-body energy ho-
meostasis (1, 2). Humans are recognized to have dis-
crete depots of BAT that have diminished thermogenic
potential in the context of chronic metabolic diseases of
aging (3). Therefore, exploiting BAT function to en-
hance energy expenditure may improve metabolic
profiles in individuals with metabolic diseases (4). BAT
is activated by cold exposure and sympathetic tone, in-
creasing the metabolic activity required for thermo-
genesis,withmanyhormonal factors playing a coordinating
role.
Glucocorticoids (GCs) are powerful regulators of
energy metabolism and recent data have revealed spe-
cies differences between humans and mice. For humans,
acute GC exposure increases, rather than suppresses,
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cold-induced BAT glucose uptake and thermogenesis
via UCP1 (5, 6). However, chronic GC exposure, in ex-
cess of normal circadian rhythm, is considered to inhibit
BAT function in both (7, 8). GC excess can repress the
expression of genes essential to BAT function, includ-
ing UCP1 (9–15), driving lipid accumulation and inhib-
iting sympathetic stimulation and cyclic adenosine
monophosphate-dependent signaling to induce thermo-
genesis (16–18). Conversely, GC depletion after adre-
nalectomy or GC receptor antagonism stimulates BAT
thermogenesis and weight loss in obese models via im-
proved BAT functionality (7, 19, 20). Importantly,
chronic GC excess in humans (i.e., Cushing’s syn-
drome) causes metabolic disease with presentation
including obesity and type 2 diabetes mellitus, with
the consequences for BAT biology being largely un-
explored (21).
The hypothalamic-pituitary-adrenal (HPA) axis de-
termines circulating GC levels, with intracellular tissue
GC levels further regulated by the activity of the enzyme
11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1),
which converts inactive 11-dehydrocorticosterone to
active corticosterone in rodents (cortisone to cortisol in
humans). Consequently, 11b-HSD1 expression can in-
fluence intracellular GC availability independently of
circulating levels. 11b-HSD1 knockout (KO) mice are
largely protected from the tissue-specific responses to
circulating GC excess and demonstrate a critical role of
the enzyme in transducing extracellular GC concentra-
tions to intracellular signaling (22, 23). 11b-HSD1 is ex-
pressed in brown adipocytes and, when overexpressed
in vitro, induces GC-mediated BAT dysfunction (24),
11b-HSD1 knockdown in vitro or after pharmacological
inhibition in vivo enhances BAT function in the face of
a high-fat diet challenge (24), and 11b-HSD1 KO mice
have been shown to have an elevated core body tem-
perature, again suggesting an influence on BAT function
(25, 26).
Here, we examine the impact of GC excess and aging
on the molecular architecture and mitochondrial activity
of murine BAT, with the hypothesis that 11b-HSD1 plays
an important role in determining the set point of GC
sensitivity. We show that 11b-HSD1 upregulation, in
response to chronic GC excess and aging, increases
brown adipocyte GC exposure to impair BAT function.
11b-HSD1 KO mice resist GC-mediated suppression of
UCP1 protein, BAT thermogenic gene-expression pro-
grams, and have preserved mitochondrial function and
activity. Thus, we reveal a physiologically relevant
mechanism of 11b-HSD1–mediated GC generation in-
hibitory to BAT function, which may have implications
for our understanding of metabolic dysregulation in GC
excess and aging.
Materials and Methods
Animal care, mouse strain, storage, and aging
Male mice (C57/BL6J) were group housed at 22°C for 10
(young) or 100 (aged) weeks. All mice were maintained in a
standard temperature- (22°C) and humidity-controlled envi-
ronment with a 12:12-hour light-dark cycle. Mice had nesting
material and ad libitum access to standard animal chow and
water. Corticosterone (CORT)- or 11-dehydrocorticosterone
(11-DHC)-supplemented drinking water (100 mg/mL, 0.66%
ethanol as a vehicle) was administered for 5 weeks. Mice were
killed by cervical dislocation, tissue was collected, individual
tissue weights recorded, and samples snap frozen in liquid ni-
trogen. Collections were all performed at 9:00 AM. Experiments
were conducted consistent with current UK Home Office reg-
ulations in accordance with the UK Animals (Scientific Pro-
cedures) Act 1986, and approved by the Animal Welfare and
Ethical Review Body.
Primary cell culture of brown adipocytes
Interscapular BAT was extracted and manually digested
before placement in collagenase, and then incubated in a 37°C
water bath for 40 minutes with 10 seconds of vortex every 5
minutes. After incubation, samples were vortexed and spun for
10 minutes at 1000 rpm and the supernatant discarded. The
remaining pellet was resuspended in 1mLof proliferationmedia
[Dulbecco’s modified Eagle medium (DMEM)/F12 culture
medium supplemented with 10% fetal calf serum and 1%
penicillin-streptomycin] and aliquots plated. The cells were
incubated at 37°C in 5% CO2 for 24 hours. The next day, the
proliferation medium was removed and cells were washed with
1 mL of fresh proliferation medium before replenishment of 1 mL
of proliferationmedium to eachwell.Cellswere incubated at 37°C
in 5% CO2 for 48 hours, with medium replacement every 24
hours. After 48 hours, the proliferationmediumwas replacedwith
1 mL of differentiation medium (DMEM/F12 culture medium
supplemented with 1 nM triiodothyronine, 2 mM rosiglitazone,
166 nM human insulin, and 1 mM dexamethasone). The cells
were allowed to differentiate at 37°C, 5% CO2, for 9 days more
with the differentiation medium changed daily.
Cell treatments
Differentiated brown adipocytes were treated in DMEM/F12
serum-free media, with CORT (1 mM; catalog no. 27840; Sigma)
or ethanol as a vehicle control for 24 hours. Treatments with CL-
316,243 hydrate (1 mM; catalog no. C5976; Sigma) were con-
ducted for 5 hourswith double-distilledwater as a vehicle control.
RNA extraction and quantitative reverse
transcription polymerase chain reaction
Total RNA was extracted from adipose tissue, using TRI
reagent (Invitrogen). RNA quality was determined by visuali-
zation on a 1.5% agarose gel and quantity was measured by
nanodrop absorbance at 260 nm. Reverse transcription was
conducted using 500 ng of RNA that was incubated with
250 mM random hexamers, 5.5 mM MgCl2, 500 mM deoxy-
nucleotide triphosphates, 20 units of RNase inhibitor, 63 units
of multiscribe reverse transcription, and 31 reaction buffer.
Reverse transcription was performed on a thermocycler set for
the following conditions: 25°C for 10 minutes and 48°C for 30
minutes before the reaction was terminated by heating to 98°C
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for 5 minutes. Complementary DNA levels were determined
using an ABI7500 system (Applied Biosystems); reactions were
conducted in a 96-well plate in singleplex format. Primers and
probes were purchased as Assay on Demand (FAM) products
(Applied Biosystems). Total reaction volumes used were 10 mL
containing Taqman Universal polymerase chain reaction (PCR)
mix (Applied Biosystems). All reactions were normalized to 18s
ribosomal RNA (VIC probe; Applied Biosystems). The real-time
PCR (RT-PCR) was performed at the following conditions: 95°C
for 10minutes, then 40 cycles at 95°C for 15 seconds, and at 60°C
for 1 minute. Data were collected as threshold cycle (Ct) values
and used to obtain the change in Ct values.
Histology of BAT
Freshly excised interscapular brown adipose depots were
dissected, processed, and embedded in paraffin wax, from
which 5-mm sections are cut for analyses via histological
staining. Hematoxylin and eosin stains were applied to the
sections. All images pertaining to histological analyses were
viewed via light microscopy and photomicrographs were taken
with a Leica imaging system using 320 magnification.
11b-HSD1 enzyme assays in BAT explants
Mouse BAT was excised and tissue samples were incubated
with 100 nm of 11-DHC diluted into 1 mL of serum-free
media in glass tubes. Tracer amounts of [H3]11DHC (syn-
thesized in house) were added and incubated for 4 hours
(27).Upon cessation of the incubation period, steroidswere
extracted from the medium with dichloromethane, sepa-
rated by thin-layer chromatography using chloroform and
ethanol in a 92:8 ratio. The fraction of converted steroids
was measured by scanning analysis using a Bioscan 2000
radioimaging detector. Conversion of 11-DHC to CORT
was calculated and normalized to tissue weight.
Mitochondrial copy number
DNA was isolated using a phenol/chloroform isomyl
alcoholmix, precipitated, and pellet rehydrated into nuclease-
free water. Samples were then measured for nucleic acid
concentration using a Nanodrop spectrophotometer
(Thermo Scientific) and diluted to normalized concentra-
tions and volume (i.e., 100 ng/mL). The NovaQUANT
Mouse Mitochondrial to Nuclear DNA Ratio Kit (catalog
no. 72621; Merck) was used to quantify mitochondrial
DNA (mtDNA) as a ratio to nuclear DNA, per manufac-
turer instructions. This compares the levels of nuclear DNA
withmtDNA in a sample using RT-PCR primers directed to
both nuclear DNA and mtDNA of equivalent amplification
efficiency, allowing expression to be compared as a ratio
of nuclear DNA to mtDNA.
Western immunoblotting
Protein lysates were collected in radioimmunoprecipitation
assay buffer (50 mmol/L Tris, pH 7.4, 1% NP40,
0.25%sodiumdeoxycholate, 150mmol/LNaCl, 1mmol/L
EDTA), 1 mmol/L phenylmethylsulfonyl fluoride, and
protease inhibitor cocktail (Roche, Lewes, United
Kingdom) stored at 280°C for 30 minutes, defrosted on
ice, and centrifuged at 4°C for 10 minutes at 12,000 rpm.
The supernatant was recovered and total protein con-
centration was assessed by Bio-Rad assay (Bio-Rad
Laboratories). Total proteins (25 mg) were resolved
on a 12% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) gel and transferred onto a
nitrocellulose membrane. Primary antibodies [UCP1:
Research Resource Identifier (RRID) AB_2213764, catalog
no. ab10983, Abcam; Mitoprofile OXPHOS Cocktail:
RRIDAB_2629281, catalog no. ab110413, Abcam; cyclic-
AMP–related response element (CREB): RRID AB_331277,
catalog no. 9197, Cell Signaling Technology; Phos-CREB
Ser-133:RRIDAB_256044, catalog no. 9198,Cell Signaling
Technology; mouse anti-b-actin: RRIDAB_306371, catalog
no. A-5441, Sigma Aldrich; and rabbit anti-11b-HSD1:
RRID AB_731458, catalog no. ab39364, Abcam]. Anti-
mouse and anti-rabbit secondary antibodies (Dako)
conjugated with horseradish peroxidase added at a dilution
of 1:10,000. Equal loading of protein content was verified
using b-actin and bands were visualized using the ECL
detection system (GE Healthcare, United Kingdom). Au-
toradiograph films were scanned and bands were measured
using ImageJ densitometry (https://imagej.nih.gov/ij/) and
normalized to those of loading control (b-actin).
Metabolic flux analysis by Seahorse XF
Primary BAT preadipocytes were isolated from culled
mice, seeded at equal densities, and differentiated for 8 to
9 days. Respiratory output and mitochondrial stress tests
were performedwith BAT in supplementedXF-Assaymedia
(25 mM glucose and 0.5 mM sodium pyruvate) at pH 7.4
and maintained for 1 hour at 37°C in 0% CO2 before
Seahorse XF analysis (Agilent Technologies). Wells were
normalized to protein concentration and expressed as pi-
comole per minute per microgram protein. Mitochondrial
functionwas assessed using the SeahorseXFCellMito Stress
Kit (catalog no. 103015-100; Agilent Technologies), oligo-
mycin (2.5 mM), carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone (5 mM), rotenone, and antimycin A
(1.0 mM). Parameters were assessed as dictated by Seahorse
Bioscience (AgilentTechnologies): basal respiration =oxygen
consumption rate (OCR) 2 nonmitochondrial respiration
rate; maximal respiration = OCR with carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone 2 nonmitochondrial res-
piration rate; and adenosine triphosphate (ATP) production =
OCR 2 OCR with oligomycin.
Statistical analysis
Student t test or analysis of variance statistical com-
parisons were used with Prism version 5 (GraphPad
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Software). Data are presented as mean 6 standard error
of the mean. Two-way analysis of variance using the
Bonferroni multiple comparison post hoc test compared
treatments and genotypes together. Unpaired t test
compared treatments or genotypes. Statistical analysis de-
rived from RT-PCR data were determined using change
in Ct values throughout.
Results
11b-HSD1KO mice resisted GC-excess–mediated
suppression of BAT
11b-HSD1 has emerged as a determinant of how GC
excess manifests tissue-specific effects in liver, muscle,
and white adipose tissue (28). We wanted to extend these
data to examine novel aspects of in vivo BAT molecular
biology with respect to the role of 11b-HSD1. To model
GC excess, we supplemented the drinking water of wild-
type (WT) and 11b-HSD1KO mice with 100 mg/mL
CORT or vehicle for 5 weeks, as previously described
(28). In this model, serumGCs were comparable between
WT and 11b-HSD1 KO mice, with both demonstrating
adrenal atrophy as a result of feedback repression of the
HPA axis (18, 28–30).
Whereas the interscapular BAT depot weight of 11b-
HSD1 KO mice was similar to that of WT mice, 11b-
HSD1 KO BAT resisted archetypal lipid accumulation
and the increase in BATmass seen inGC-treatedWTmice
[Fig. 1(a)]. Hematoxylin and eosin staining showed that
GC-treated WT BAT had increases in lipid droplet size
compared with that of untreatedWT and 11b-HSD1 KO
mice. However, there was an increase in lipid droplet size
in GC-treated 11b-HSD1 KO BAT compared with ve-
hicle treated, but not to the same degree as in WT mice
[Fig. 1(b)].
GCs can increase the expression and activity of 11b-
HSD1 inWTmice and this study shows exposure of BAT
to GC excess stimulates 11b-HSD1 transcription in WT
mice but has no effect upon the GC receptor [GR (or
NR3C1); Fig. (c)]. Increased BAT 11b-HSD1 expression
was endorsed by showing increased levels of enzyme
activity from WT BAT explants [Fig. 1(d)].
We next evaluated BAT status in untreatedmice, using
established expression profiles. UCP1 mRNA levels were
unchanged compared with WT BAT, but 11b-HSD1 KO
BAT did display a profile associated with enhanced BAT
function, with increased mRNA abundance of genes
integral to efficient metabolic function andmitochondrial
biogenesis, such as ELOVL3, DIO2, TFAM, and NRF1
[Fig. 1(e)]. Because GCs repress b-adrenergic stimulation
of BAT, UCP1 expression, and overall thermogenic ca-
pacity, we reasoned that deficiency of 11b-HSD1 would
help preserve BAT function in the context of GC excess.
Again, UCP1 mRNA did not show a discernible differ-
ence between 11b-HSD1 KO andWT BAT. However, as
in untreated mice, GC-treated 11b-HSD1KO mice re-
tained an elevated expression profile of markers seen in
the untreated state [COX7A1, COXIV, TFAM, NRF1,
ELOVL3, and DIO2; (Fig. 1(f)].
UCP1 mRNA levels do not always predict the level of
protein; therefore, we assessed UCP1 protein and showed
that although GC repressed UCP1 expression in WT
BAT, 11b-HSD1KO BAT was resistant to this and
retained elevated levels [Fig. 1(g) and 1(h)]. 11b-
HSD1KO BAT was also protected from GC-induced
decreases in mitochondrial copy number [Fig. 1(i)]. We
extended this to evaluate subunits of the mitochondrial
respiratory chain [Fig. 1(j) and 1(k)]. Although GC re-
pressed WT BAT mitochondrial subunit expression, in
line with a decreased mitochondrial copy number, 11b-
HSD1KO had significantly preserved subunits of CI, CII,
and CV, indicative of protection from the deleterious
effects of excess GC on mitochondrial capacity. Thus,
the absence of 11b-HSD1 was mildly protective in the
basal state, and became more prominent with chronic
GC excess.
Previous studies have demonstrated that 11b-HSD1KO
mice are also protected from the effect of circulating 11-
DHC excess in various tissues (28, 31). Here, we show
that this effect is also evident for BAT, with 11b-HSD1
KO mice exposed to 11-DHC–supplemented drinking
water having greater levels of UCP1 and expression
markers indicative of retained mitochondrial and BAT
function compared with 11-DHC–treated WT mice
[Supplemental Fig. 1(A–D)].
11b-HSD1 regulates brown adipocyte sensitivity
to GC
Having shown the impact of 11b-HSD1 deficiency
on the molecular characteristics of BAT in WT and 11b-
HSD1 KO mice, we explored the cell autonomous sen-
sitivity of brown adipocytes to GCs and temperature.
Using differentiated primary brown adipocyte cultures
derived from 11b-HSD1 KO andWTmice, we examined
responses of cells treated with 1 mm of CORT for 24
hours.
We confirmed in vitro and in vivo 11b-HSD1 mRNA
induction in WT cells in response to GCs [Fig. 2(a)]. We
extended our analysis to show, in vivo, that GCs have
the effect of suppressing markers of brown adipocyte
function [Fig. 2(b)], in agreement with previous studies
(24). Brown adipocytes derived from 11b-HSD1 KO
mice had augmented expression of BAT metabolic and
mitochondrial markers, with increased UCP1, COX8B,
COX7A1, PGC1A, PPARG, and CIDEA expression
[Fig. 2(b)]. Although basal expression of BAT markers
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Figure 1. 11b-HSD1 KO amplifies favorable stress response and mitochondrial metabolic activity of murine BAT. Ten-week-old WT and 11b-
HSD1 KO mice were maintained for 5 weeks on vehicle or CORT-spiked drinking water. Upon cessation, interscapular BAT was excised and its
weight recorded. (a, b) Hematoxylin-and-eosin staining was performed on formalin-fixed BAT. (c) RNA was isolated from the BAT and measured
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was elevated in 11b-HSD1 KO cells, GC treatments did
suppress expression in both WT and KO mice for UCP1,
COX8B, and COX7A1, whereas, PGC1A, PPARG, and
CIDEA, in bothWT and KO cells, did not respond to GC
treatment [Fig. 2(b)].Cold induces the sympathetic ner-
vous system and b-adrenergic signaling to stimulate the
BAT thermogenic program (32). To explore further a cell
autonomous role for 11b-HSD1 inmodulating responses to
cold via thermogenic gene programs, we exposedWT- and
11b-HSD1 KO-derived primary brown adipocyte cultures
to a cooler culture temperature (30°C). WT BAT-derived
adipocytes showed a significant induction of the thermo-
genic transcriptional program when cells were cultured at
30°C [Fig. 2(c)]. Similarly, 11b-HSD1 KO-derived adipo-
cytes showed again that the thermogenic program was
expressed to a greater degree than in WT cells [Fig. 2(c)].
We next examined how the expression signature re-
lated to a functional output as assessed by cellular oxygen
consumption rate (OCR) as a measure of energy ho-
meostasis in the presence of CORT and the b-3 adren-
ergic receptor agonist CL316,243 [Fig. 3(a) and 3(b)].
Untreated cells showed that 11b-HSD1 KO brown adi-
pocytes had significantly increased basal, maximal,
and ATP production levels compared with WT adipo-
cytes, demonstrating an elevated level of respiration
[Fig. 3(c)]. CORT excess significantly depressed the
basal and maximal rates of WT but not 11b-HSD1 KO
adipocytes. However, 11b-HSD1 KO adipocytes were im-
paired by CORT when measuring ATP production,
suggesting the protective effect does not fully extended to
coupled respiration, although it is still significantly higher
than the CORT treated WT. CL316,243 was able to
induce both WT and 11b-HSD1KO basal and maximal
OCR in cells at proportional rates. Conversely, ATP
production in WT and 11b-HSD1KO adipocytes treated
with CL316,243 failed to reach significance in compar-
ison with untreated cells [Fig. 3(c–e)].
Elevated BAT 11b-HSD1 expression in aged mice
Given that 11b-HSD1-mediated GC metabolism
plays a role in determining themolecular set point of BAT
thermogenic and mitochondrial capacity, we reasoned
that a lifelong loss of 11b-HSD1 (i.e. chronically atten-
uatedGC signaling) would enhancemolecularmarkers of
BAT function. To test this, we examined archived BAT
tissue from 100-week-old 11b-HSD1 KO mice that
were fed a standard rodent chow under standard animal
house conditions. First, we examined BAT 11b-HSD1
expression in aged WT mice compared with isogenic
young mice and observed that both mRNA and protein
were markedly elevated compared with young WT mice,
without changes in the expression of the GC receptor
[Fig. 4(a–c)].
Elevated molecular markers of BAT thermogenic
potential in aged 11b-HSD1 KO mice
Recent data show that elevated 11b-HSD1 expression
in BAT impairs mitochondrial fatty acid oxidation ca-
pacity of BAT (33). As such, elevated 11b-HSD1 and
increased intracellular GC availability in BAT from our
aged mice may have acted to suppress maximal BAT
potential. Aged 11b-HSD KO mice had increased
interscapular BAT mass compared with aged WT mice
[Fig. 5(a)]. Again, we found no significant difference in
UCP1 mRNA levels but found threefold greater UCP1
protein levels compared with WT mice, suggesting in-
creased potential for UCP1-mediated thermogenic ac-
tivity [Fig. 5(b–d)]. In support of this, BAT from aged
11b-HSD1 KO mice also displayed increased expression
levels of markers important to thermogenic potential and
mitochondrial function [Fig. 5(e)]. We next examined
mitochondrial copy number and protein content. Aged
11b-HSD1 KO BAT had an elevated mitochondrial copy
number, endorsed by elevated levels of mitochondrial
respiratory subunits, particularly CI and CIV [Fig. 5(f–h)].
Finally, we show elevated CREB serine-133 phos-
phorylation as evidence of increased functional potential of
BAT from 11b-HSD1 KOmice, because it is demonstrated
to play a role in SIRT3-mediated activation of PGC1A and
increased oxygen consumption within brown adipocytes
[Fig. 5(i) and 5(j)] (34). These data highlight, in the context
of normal murine aging physiology, that 11b-HSD1 can
act as a restraint to BAT through repression of genes
controlling thermogenic capacity and mitochondrial turn-
over or biogenesis.
Discussion
Exposure of human and mouse BAT to chronically ele-
vated GC levels impairs function by interfering with
Figure 1. (Continued). using quantitative reverse transcription PCR for 11b-HSD1 and GR (NR3C1). (d) 11b-HSD1 enzyme activity levels
recorded in WT and 11b-HSD1 KO explants. (e, f) RNA from 11b-HSD1 KO and 11b-HSD1 KO plus CORT BAT measured for BAT regulators,
components of mitochondrial respiration, and mitochondrial biogenesis, and compared with WT and WT plus CORT, respectively. (g, h) Protein
expression of UCP1 measured by (g) SDS-PAGE and (h) quantified. (i) mtDNA copy number also was assessed in the extracted BAT. WT and 11b-
HSD1 KO BAT protein observation of mitochondrial respiratory complexes with and without CORT were conducted by ( j) SDS-PAGE and
mitochondrial oxidative phosphorylation antibody cocktail. (k) Quantification results. Group sizes were 6 to 10 mice. All values are presented as
mean 6 standard error of the mean. (a, c, d, h, i, k) Assessed using two-way analysis of variance with Bonferroni post hoc test. (e, f ) Analyzed
using unpaired t test. *P , 0.05; **P , 0.01; ***P , 0.001.
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Figure 2. 11b-HSD1 KO protection from GC exposure in brown adipocytes is cell autonomous. (a) RNA for 11b-HSD1 was measured using
quantitative reverse transcription PCR in WT and 11HSD1 KO mice treated with or without CORT-spiked drinking water. Primary brown
adipocytes from WT and 11b-HSD1 KO mice were cultured and differentiated. (b) RNA analysis of key BAT regulators and mitochondrial
metabolic factors from BAT maintained at 37°C with and without CORT was measured by quantitative reverse transcription PCR. (c) Comparison
of quantitative reverse transcription PCR data from WT and 11b-HSD1 KO brown adipocytes stored at 30°C and 37°C. Group sizes were six to
eight mice. (a–c) Statistical assessment was performed using two-way analysis of variance with Bonferroni post hoc test. All values are presented
as mean 6 standard error of the mean. *P , 0.05; **P , 0.01; ***P , 0.001.
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sympathetic adrenergic signaling and suppression of
transcriptional programs that regulate nonshivering
thermogenesis (15, 35). Here, we provide evidence that
elevated 11b-HSD1 expression within brown adipo-
cytes, as a consequence of GC excess and aging, can
impair the BAT thermogenic program, mitochondrial
biogenesis, and respiratory capacity. As such, 11b-
HSD1-mediated GC generation can influence the ability
of BAT to execute its primary function of thermogenic
regulation (Fig. 6).
Within normal physiology, 11b-HSD1 performs as a
gatekeeper, locally tuning active GC exposure on a tissue-
specific basis. Global 11b-HSD1 KO mice display car-
dioprotective phenotypes in the context of high-fat diets
or in models of atherosclerosis (36). Little is understood
of the in vivo role 11b-HSD1 plays in BAT physiology
Figure 3. 11b-HSD1 KO protection from GC exposure in brown adipocytes is cell autonomous. Primary brown adipocytes from WT and 11b-
HSD1 KO mice were cultured and differentiated. (a, b) Basal OCR and mitochondrial assessment was measured (a) with and without CORT or (b)
with and without CL316,243. (c–e) Respiration parameters were calculated for (c) basal, (d) maximal, and (e) ATP production conditions. Group
sizes were three to five mice. All values are presented as mean 6 standard error of the mean. (a–e) Statistical significance was calculated using
two-way analysis of variance with Bonferroni post hoc test. *P , 0.05; **P , 0.01; ***P , 0.001.
Figure 4. 11b-HSD1 expression is increased in aged mice maintained at standard animal house conditions. Aged (100 weeks) WT and 11b-HSD1
KO mice were collected and BAT excised. (a) RNA levels of 11b-HSD1 and GR measured by quantitative reverse transcription PCR. (b, c) Protein
levels of 11b-HSD1 were recorded along with b-actin as a loading control. Group sizes were 10 to 12 mice. All values are presented as mean 6
standard error of the mean. (a–c) Statistical significance was calculated using unpaired t test. *P , 0.05; **P , 0.01; ***P , 0.001.
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Figure 5. 11b-HSD1 KO BAT shows enhanced molecular markers of mitochondrial function during aging. Aged (100 weeks) WT and 11b-HSD1
KO BAT was removed. (a) BAT weight recorded and expressed as a ratio of total body weight (BW). (b–d) Levels of UCP1 in both RNA and
protein were measured in aged WT and 11b-HSD1 KO BAT. (e) RNA expression of stated integral components of BAT mitochondrial function. (f)
mtDNA expressed as a ratio to nuclear DNA measured in BAT collected from WT and 11b-HSD1 KO aged mice. (g–j) SDS-PAGE of protein in
aged WT and 11b-HSD1 KO BAT performed for oxidative phosphorylation subunits (g, h) and CREB phosphorylation (i, j). Group sizes were 8 to
12 mice. All values presented as mean 6 standard error of the mean. (a–j) Statistical significance was calculated using an unpaired t test with
significance at *P , 0.05, **P , 0.01, and ***P , 0.001.
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other than that 11b-HSD1 KO mice have elevated core
temperature, and adipose-overexpressing transgenic
mice have suppressed UCP1 mRNA expression (25, 37).
Tissue-specific GC excess in WT mice, and ensuing
metabolic disease (e.g., myopathy, hepatic steatosis,
hypertension), is a function of increased circulating
delivery of the inactive GC precursor 11-DHC after
kidney (and, to a lesser extent, colon and salivary
glands) 11b-HSD2 activity converting CORT to 11-
DHC, and GC-mediated increases in 11b-HSD1 ex-
pression and activity. However, 11b-HSD1KOmice are
protected from this classical metabolic phenotype, under-
scoring the importance of 11b-HSD1 to mediate path-
ophysiology (28, 38).
We show that both circulating GC excess and ad-
vanced age share the common feature of transcriptional
upregulation of BAT 11b-HSD1 and elevated intracellu-
lar GC regeneration, which negatively impact functional
markers. The idea that inappropriate 11b-HSD1 ex-
pression leads to poor BAT function is endorsed in
recent findings that the epigenetic regulator lysine-
specific demethlyase-1 represses 11b-HSD1, such that
lysine-specific demethlyase-1 loss of function leads to
inappropriately elevated expression and activity to im-
pair BAT mitochondrial metabolic function (33).
UCP1 is critical to the ability of BAT to dissipate
chemical energy as heat, and a consistent finding in our
data was that 11b-HSD1 KOmice, whether young, aged,
or when subject to GC excess, displayed elevated UCP1
protein levels, despite mRNA equivalent to WT mice.
UCP1 mRNA levels do not always predict the level of
protein, and discrepancy between transcriptional output
and translational product of UCP1 have been observed
previously; thus, here, they may be attributable to a
prolonged half-life and extended posttranslational sta-
bility (39, 40). Thus, elevated UCP1 protein in 11b-HSD1
KO BAT would increase the potential for efficient BAT
thermogenic activity, in line with previous work (41).
We provide evidence that a consequence of elevated
11b-HSD1 expression and activity in GC excess and
aging is the suppression of mitochondrial electron
transport chain subunit content, which is rescued in the
absence of 11b-HSD1. Indeed, 11b-HSD KO BAT dis-
plays an enhanced transcriptional signature of classical
mitochondrial markers and resists suppression of fac-
tors influencing mitochondrial biogenesis. GC receptor
regulation of nuclear genes involved in mitochondrial
energy metabolism has been demonstrated, and mito-
chondrial localization of GR may also directly influence
transcription of mitochondrial genes (42–44). In par-
ticular, the identification of various GC-responsive el-
ements contained within the mitochondrial genome has
been shown by a number of studies in a variety of tissues
(predominantly neuronal, hematopoietic progenitors,
and liver cells), including changes in expression of
the oxidative phosphorylation complexes (45–47). This
leads to the intriguing potential for GC excess within
BAT being partially dictated through mtDNA-GR in-
teraction. Evidence exists for a GR-mediated role in
mitochondrial-nuclear shuttling, driving differentiation
and the adipogenic phenotype (48). As such, these data
hint that 11b-HSD1 expression may influence mito-
chondrial function, requiring further investigation.
To assess whether the in vivo findings extended to
cell autonomous brown adipocyte responses to GC and
temperature in the absence of 11b-HSD1, we evaluated
primary cultures. Again, 11b-HSD1 KO cells displayed
an enhanced brown adipocyte gene expression profile
but were more sensitive to suppression when exogenous
GC was administered. In vivo, the BAT thermogenic
program is stimulated by cold temperatures (2), and cold
exposure can rescue metabolic disturbances due to GC
excess (18).We show that 11b-HSD1 KO-derived brown
adipocytes at 30°C had exaggerated transcriptional re-
sponses compared withWT adipocytes, highlighting that
11b-HSD1 is at least important for establishing basal
expression.
11b-HSD1KO cells had increased basal and maximal
respiratory rates, increased ATP production, and resisted
GC-induced suppression. CL316,243 activates b-adre-
noreceptors in brown adipose (49), and 11b-HSD1 KO
cells treated with this agonist, while displaying increased
absolute basal and maximal oxygen consumption, had
Figure 6. Schematic diagram indicating the impact of excess local
GC activation by 11b-HSD1 upon BAT function. Stressors such as
age related increase in 11b-HSD1 expression and chronic excess GC
exposure propagates loss of function in mitochondria, mitochondrial
biogenesis, and oxidative metabolism of murine BAT.
doi: 10.1210/en.2016-1722 https://academic.oup.com/endo 1973
similar relative induction to WT-treated cells, implying
that lack of 11b-HSD1 does not augment b-adrenergic
signaling in this in vitro system. Why cells removed from
sympathetic innervation, and circulatory delivery of active
and inactive GC, display a cell autonomous phenotype is
not entirely clear. The primary cultures were generated in
the presence of fetal bovine serum (refreshed daily), which
contained GCs (50). Additionally, the cocktail of factors
supporting primary brown adipocytes contains dexa-
methasone (a prerequisite for differentiation), which, in
WT cells, could maximize 11b-HSD1 expression and
activity and further enhance GC activation, with 11b-
HSD1KO cells protected from these effects.
Concomitant with aging, 11b-HSD1 expression is
elevated in numerous tissues, such as skin and brain
regions, and we demonstrate this to be true for BAT
(51, 52). A mechanism for increased 11b-HSD1 ex-
pression with age is not clear and may reflect tissue-
specific responses to inflammatory signals, alterations
in the epigenetic landscape, hormone decline, chronic
stress, and alterations in HPA axis activity that subtly
but chronically increase GC exposure (30).With this in
mind, we present evidence that aged BAT from 11b-
HSD1 KO mice displays a profile in keeping with
greater thermogenic potential than age-matched WT
mice. UCP1 protein was increased, as was relative
mitochondrial copy number and electron transport
chain protein content. Furthermore, aged tissue ap-
pears to display greater levels of phosphorylated
CREB, which may imply enhanced thermogenic po-
tential acting through the b-adrenoreceptor pathway
(53). GCs are known to interfere with this signaling
pathway (54, 55). Although we did not observe this
protection in the context of GC excess, lifelong 11b-
HSD1 deficiency may alter tone sufficiently to increase
CREB phosphorylation.
The emerging species differences between humans and
mice in terms of acute UCP1 and BAT thermogenic re-
sponses to GC is intriguing and may yet yield important
insights to human BAT physiology and have implica-
tions for future translational work (5, 6). In addition,
acute dexamethasone enhances 11b-HSD1 gene ex-
pression in human BAT to a greater extent than in white
adipose tissue, which also poses further implications
when delineating results between species (6). However,
chronic GC exposure appears to have the same impact on
BAT for both species, endorsing the utility of the data
presented here.
In summary, our data support the idea that 11b-HSD1
can set the sensitivity of murine BAT to GC, and that
elevated 11b-HSD1 expression contributes to the path-
ophysiological mechanisms negatively impacting BAT
thermogenic capacity in the context of GC excess and
aging.
Acknowledgments
Address all correspondence and requests for reprints to: Gareth
G. Lavery, PhD, Wellcome Trust Senior Research Fellow, In-
stitute of Metabolism and Systems Research, University of
Birmingham, Edgbaston, Birmingham B15 2TT, United King-
dom. E-mail: g.g.lavery@bham.ac.uk.
This work was supported by Biotechnology and Biological
Sciences Research Council (BBSRC) David Philips Fellowship
GGL-BB/G023468/1 and BBSRC CASE Studentship SAM-
BBB/S/M/2006/13045, Wellcome Trust Senior Fellowship
GGL-104612/Z/14/Z, Wellcome Trust Grant PMS-082809,
European Research Council Advanced Grant PMS-20090506,
BBSRC New Investigator Award AP-BB/L023547/1, and a So-
ciety for Endocrinology Early Career grant (C.L.D.). Seahorse
metabolic flux analysis was performed through the University
of Birmingham Mitochondrial Profiling Centre, an open access
facility supported by the Medical Research Council and the
University of Birmingham Dynamic Investment Fund.
Author contributions: C.L.D., R.S.F., S.A.M., E.L.M., and
D.P.L. performed the experiments. C.L.D., A.P., and G.G.L.
wrote the manuscript. C.L.D., J.W.T., P.M.S., and G.G.L.
conceived and designed the study.
Disclosure Summary: The authors have nothing to disclose.
References
1. Enerba¨ck S, Jacobsson A, Simpson EM, Guerra C, Yamashita H,
Harper ME, Kozak LP. Mice lacking mitochondrial uncoupling
protein are cold-sensitive but not obese. Nature. 1997;387(6628):
90–94.
2. Cannon B, Nedergaard J. Nonshivering thermogenesis and its
adequate measurement in metabolic studies. J Exp Biol. 2011;
214(pt 2):242–253.
Appendix. Antibody Table
Peptide/Protein Target Antibody Manufacturer, Catalog No.; RRID Species Raised in Dilution
UCP1 UCP1 Abcam, Ab23841; RRID 2213764 Rabbit 1/10,000
Mitochondrial OXPHOS
subunits (1-5)
OXPHOS cocktail Abcam, Ab110413; RRID AB_2629281 Rodent 1/10,000
b-actin b-actin Abcam, Ab8226; RRID AB_306371 Mouse 1/10,000
CREB total CREB total Cell Signaling, 9197; RRID AB_331277 Rabbit 1/1000
Phos-CREB Ser-133 Phos-CREB Ser-133 Cell Signaling, 9198; RRID AB 256044 Rabbit 1/1000
11b-HSD1 11b-HSD1 Abcam, Ab39364; RRID AB_731458 Rabbit 1/1000
1974 Doig et al 11b-HSD1 KO Augments BAT Metabolic Function Endocrinology, June 2017, 158(6):1964–1976
3. McDonald RB, Horwitz BA. Brown adipose tissue thermogenesis
during aging and senescence. J Bioenerg Biomembr. 1999;31(5):
507–516.
4. Yoneshiro T, Aita S,MatsushitaM, Kayahara T, Kameya T, Kawai
Y, Iwanaga T, Saito M. Recruited brown adipose tissue as an
antiobesity agent in humans. J Clin Invest. 2013;123(8):
3404–3408.
5. Ramage LE, Akyol M, Fletcher AM, Forsythe J, Nixon M, Carter
RN, van Beek EJ, Morton NM, Walker BR, Stimson RH. Glu-
cocorticoids acutely increase brown adipose tissue activity in
humans, revealing species-specific differences in UCP-1 regulation.
Cell Metab. 2016;24(1):130–141.
6. Barclay JL, AgadaH, JangC,WardM,WetzigN,HoKK. Effects of
glucocorticoids on human brown adipocytes. J Endocrinol. 2015;
224(2):139–147.
7. Feldman D. Evidence that brown adipose tissue is a glucocorticoid
target organ. Endocrinology. 1978;103(6):2091–2097.
8. Feldman D, Hirst M. Glucocorticoids and regulation of phos-
phoenolpyruvate carboxykinase activity in rat brown adipose tis-
sue. Am J Physiol. 1978;235(2):E197–E202.
9. Hernandez R, Teruel T, Lorenzo M. Insulin and dexamethasone
induce GLUT4 gene expression in foetal brown adipocytes: syn-
ergistic effect through CCAAT/enhancer-binding protein alpha.
Biochem J. 2003;372(pt 2):617–624.
10. Scarpace PJ, Baresi LA,Morley JE. Glucocorticoids modulate beta-
adrenoceptor subtypes and adenylate cyclase in brown fat. Am J
Physiol. 1988;255(2 pt 1):E153–E158.
11. Buyse M, Viengchareun S, Bado A, Lombe`s M. Insulin and glu-
cocorticoids differentially regulate leptin transcription and secre-
tion in brown adipocytes. FASEB J. 2001;15(8):1357–1366.
12. Kong X, Yu J, Bi J, Qi H, DiW,Wu L,Wang L, Zha J, Lv S, Zhang
F, Li Y, Hu F, Liu F, Zhou H, Liu J, Ding G. Glucocorticoids
transcriptionally regulate miR-27b expression promoting body fat
accumulation via suppressing the browning of white adipose tissue.
Diabetes. 2015;64(2):393–404.
13. Strack AM, Bradbury MJ, Dallman MF. Corticosterone decreases
nonshivering thermogenesis and increases lipid storage in brown
adipose tissue. Am J Physiol. 1995;268(1 Pt 2):R183–R191.
14. Santana P, Akana SF, Hanson ES, Strack AM, Sebastian RJ,
Dallman MF. Aldosterone and dexamethasone both stimulate
energy acquisition whereas only the glucocorticoid alters energy
storage. Endocrinology. 1995;136(5):2214–2222.
15. Viengchareun S, Penfornis P, Zennaro MC, Lombe`s M. Mineral-
ocorticoid and glucocorticoid receptors inhibit UCP expression and
function in brown adipocytes. Am J Physiol Endocrinol Metab.
2001;280(4):E640–E649.
16. Campbell JE, Peckett AJ, D’souza AM, Hawke TJ, Riddell MC.
Adipogenic and lipolytic effects of chronic glucocorticoid exposure.
Am J Physiol Cell Physiol. 2011;300(1):C198–C209.
17. Brown MR, Fisher LA. Glucocorticoid suppression of the sym-
pathetic nervous system and adrenal medulla. Life Sci. 1986;
39(11):1003–1012.
18. van den Beukel JC, Boon MR, Steenbergen J, Rensen PC, Meijer
OC, Themmen AP, Grefhorst A. Cold exposure partially corrects
disturbances in lipid metabolism in a male mouse model of glu-
cocorticoid excess. Endocrinology. 2015;156(11):4115–4128.
19. Couto RC, Couto GE, Oyama LM, Daˆmaso AR, Silveira VL,
Nascimento CM. Effect of adrenalectomy and glucocorticoid
therapy on lipid metabolism of lactating rats. Horm Metab Res.
1998;30(10):614–618.
20. Moriscot A, Rabelo R, Bianco AC. Corticosterone inhibits
uncoupling protein gene expression in brown adipose tissue. Am J
Physiol. 1993;265(1 Pt 1):E81–E87.
21. Stewart PM. Tissue-specific Cushing’s syndrome, 11beta-
hydroxysteroid dehydrogenases and the redefinition of cortico-
steroid hormone action. Eur J Endocrinol. 2003;149(3):163–168.
22. Clark SJ, Schmidt CQ, White AM, Hakobyan S, Morgan BP,
Bishop PN. Identification of factor H-like protein 1 as the pre-
dominant complement regulator in Bruch’s membrane: implications
for age-related macular degeneration. J Immunol. 2014;193(10):
4962–4970.
23. Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM.
Expression of 11beta-hydroxysteroid dehydrogenase type 1 in
adipose tissue is not increased in human obesity. J Clin Endocrinol
Metab. 2002;87(12):5630–5635.
24. Liu J, KongX,Wang L,Qi H, DiW, ZhangX,Wu L, ChenX, Yu J,
Zha J, Lv S, Zhang A, Cheng P, HuM, Li Y, Bi J, Li Y, Hu F, Zhong
Y, Xu Y, Ding G. Essential roles of 11b-HSD1 in regulating brown
adipocyte function. J Mol Endocrinol. 2013;50(1):103–113.
25. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B,
Fievet C, Walker BR, Flier JS, Mullins JJ, Seckl JR. Novel adipose
tissue-mediated resistance to diet-induced visceral obesity in 11
beta-hydroxysteroid dehydrogenase type 1-deficient mice.Diabetes.
2004;53(4):931–938.
26. Morton NM, Holmes MC, Fie´vet C, Staels B, Tailleux A, Mullins
JJ, Seckl JR. Improved lipid and lipoprotein profile, hepatic insulin
sensitivity, and glucose tolerance in 11beta-hydroxysteroid de-
hydrogenase type 1 null mice. J Biol Chem. 2001;276(44):
41293–41300.
27. Bujalska IJ, Walker EA, Tomlinson JW, Hewison M, Stewart PM.
11Beta-hydroxysteroid dehydrogenase type 1 in differentiating
omental human preadipocytes: from de-activation to generation of
cortisol. Endocr Res. 2002;28(4):449–461.
28. Morgan SA,McCabeEL,Gathercole LL,Hassan-SmithZK, Larner
DP, Bujalska IJ, Stewart PM, Tomlinson JW, Lavery GG. 11b-
HSD1 is the major regulator of the tissue-specific effects of cir-
culating glucocorticoid excess. Proc Natl Acad Sci USA. 2014;
111(24):E2482–E2491.
29. Razzoli M, Frontini A, Gurney A, Mondini E, Cubuk C, Katz LS,
Cero C, Bolan PJ, Dopazo J, Vidal-Puig A, Cinti S, Bartolomucci A.
Stress-induced activation of brown adipose tissue prevents obesity
in conditions of low adaptive thermogenesis. Mol Metab. 2015;
5(1):19–33.
30. Nedergaard J, Cannon B. The changed metabolic world with hu-
man brown adipose tissue: therapeutic visions. Cell Metab. 2010;
11(4):268–272.
31. Harno E, Cottrell EC, Yu A, DeSchoolmeester J, Gutierrez PM,
Denn M, Swales JG, Goldberg FW, Bohlooly-Y M, Anderse´n H,
Wild MJ, Turnbull AV, Leighton B, White A. 11b-Hydroxysteroid
dehydrogenase type 1 (11b-HSD1) inhibitors still improve meta-
bolic phenotype in male 11b-HSD1 knockout mice suggesting off-
target mechanisms. Endocrinology. 2013;154(12):4580–4593.
32. Nedergaard J, Golozoubova V, Matthias A, Asadi A, Jacobsson A,
Cannon B. UCP1: the only protein able to mediate adaptive non-
shivering thermogenesis and metabolic inefficiency. Biochim Bio-
phys Acta. 2001;1504(1):82–106.
33. Zeng X, Jedrychowski MP, Chen Y, Serag S, Lavery GG, Gygi SP,
Spiegelman BM. Lysine-specific demethylase 1 promotes brown
adipose tissue thermogenesis via repressing glucocorticoid activa-
tion. Genes Dev. 2016;30(16):1822–1836.
34. Shi T, Wang F, Stieren E, Tong Q. SIRT3, a mitochondrial sirtuin
deacetylase, regulates mitochondrial function and thermogenesis in
brown adipocytes. J Biol Chem. 2005;280(14):13560–13567.
35. Soumano K, Desbiens S, Rabelo R, Bakopanos E, Camirand A,
Silva JE. Glucocorticoids inhibit the transcriptional response of the
uncoupling protein-1 gene to adrenergic stimulation in a brown
adipose cell line. Mol Cell Endocrinol. 2000;165(1-2):7–15.
36. Anil TM, Dandu A, Harsha K, Singh J, Shree N, Kumar VS,
Lakshmi MN, Sunil V, Harish C, Balamurali GV, Naveen Kumar
BS, Gopala AS, Pratibha S, Sadasivuni M, Anup MO, Moolemath
Y, Venkataranganna MV, Jagannath MR, Somesh BP. A novel
11b-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49
improves hyperglycemia, lipid profile and reduces body weight in
diet induced obese C57B6/J mice with a potential to provide cardio
protective benefits. BMC Pharmacol Toxicol. 2014;15:43.
37. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ,
Seckl JR, Flier JS. A transgenic model of visceral obesity and the
metabolic syndrome. Science. 2001;294(5549):2166–2170.
doi: 10.1210/en.2016-1722 https://academic.oup.com/endo 1975
38. Morgan SA, Gathercole LL, Simonet C, Hassan-Smith ZK,
Bujalska I, Guest P, Abrahams L, Smith DM, Stewart PM, Lavery
GG, Tomlinson JW. Regulation of lipid metabolism by glucocor-
ticoids and 11b-HSD1 in skeletal muscle. Endocrinology. 2013;
154(7):2374–2384.
39. Nedergaard J, Cannon B. UCP1 mRNA does not produce heat.
Biochim Biophys Acta. 2013;1831(5):943–949.
40. Puigserver P, Herron D, Gianotti M, Palou A, Cannon B, Neder-
gaard J. Induction and degradation of the uncoupling protein
thermogenin in brown adipocytes in vitro and in vivo. Evidence
for a rapidly degradable pool.Biochem J. 1992;284(Pt 2):393–398.
41. Li G, Hernandez-Ono A, Crooke RM, GrahamMJ, Ginsberg HN.
Antisense reduction of 11b-hydroxysteroid dehydrogenase type 1
enhances energy expenditure and insulin sensitivity independent of
food intake in C57BL/6J mice on a Western-type diet.Metabolism.
2012;61(6):823–835.
42. Koufali MM, Moutsatsou P, Sekeris CE, Breen KC. The dynamic
localization of the glucocorticoid receptor in rat C6 glioma cell
mitochondria. Mol Cell Endocrinol. 2003;209(1-2):51–60.
43. Sionov RV, Kfir S, Zafrir E, Cohen O, Zilberman Y, Yefenof E.
Glucocorticoid-induced apoptosis revisited: a novel role for glu-
cocorticoid receptor translocation to the mitochondria. Cell Cycle.
2006;5(10):1017–1026.
44. Sionov RV, Cohen O, Kfir S, Zilberman Y, Yefenof E. Role of
mitochondrial glucocorticoid receptor in glucocorticoid-induced
apoptosis. J Exp Med. 2006;203(1):189–201.
45. Psarra AM, Sekeris CE. Glucocorticoids induce mitochondrial
gene transcription in HepG2 cells: role of the mitochondrial
glucocorticoid receptor. Biochim Biophys Acta. 2011;1813(10):
1814–1821.
46. Talabe´r G, Boldizsa´r F, Bartis D, Pa´linka´s L, Szabo´ M, Berta G,
Se´ta´lo´ G, Jr, Ne´meth P, Berki T.Mitochondrial translocation of the
glucocorticoid receptor in double-positive thymocytes correlates
with their sensitivity to glucocorticoid-induced apoptosis. Int
Immunol. 2009;21(11):1269–1276.
47. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, Khairova
R, Zhou R, Yuan P, Machado-Vieira R, McEwen BS, Manji HK.
Dynamic regulation of mitochondrial function by glucocorticoids.
Proc Natl Acad Sci USA. 2009;106(9):3543–3548.
48. Toneatto J, Guber S, Charo´ NL, Susperreguy S, Schwartz J,
Galigniana MD, Piwien-Pilipuk G. Dynamic mitochondrial-
nuclear redistribution of the immunophilin FKBP51 is regu-
lated by the PKA signaling pathway to control gene expression
during adipocyte differentiation. J Cell Sci. 2013;126(Pt 23):
5357–5368.
49. Ghorbani M, Himms-Hagen J. Appearance of brown adipocytes in
white adipose tissue during CL 316,243-induced reversal of obesity
and diabetes in Zucker fa/fa rats. Int J Obes Relat Metab Disord.
1997;21(6):465–475.
50. Brunner D, Frank J, Appl H, Scho¨ffl H, PfallerW, Gstraunthaler G.
Serum-free cell culture: the serum-free media interactive online
database. ALTEX. 2010;27(1):53–62.
51. Yau JL, Noble J, Kenyon CJ, Hibberd C, Kotelevtsev Y,
Mullins JJ, Seckl JR. Lack of tissue glucocorticoid reactivation in
11beta -hydroxysteroid dehydrogenase type 1 knockout mice
ameliorates age-related learning impairments. Proc Natl Acad Sci
USA. 2001;98(8):4716–4721.
52. TiganescuA, Tahrani AA,Morgan SA, OtrantoM, Desmoulie`re A,
Abrahams L, Hassan-Smith Z, Walker EA, Rabbitt EH, Cooper
MS, Amrein K, Lavery GG, Stewart PM. 11b-Hydroxysteroid
dehydrogenase blockade prevents age-induced skin structure and
function defects. J Clin Invest. 2013;123(7):3051–3060.
53. Ye L, Wu J, Cohen P, Kazak L, Khandekar MJ, Jedrychowski MP,
Zeng X, Gygi SP, Spiegelman BM. Fat cells directly sense tem-
perature to activate thermogenesis. Proc Natl Acad Sci USA. 2013;
110(30):12480–12485.
54. Imai E, Miner JN, Mitchell JA, Yamamoto KR, Granner DK.
Glucocorticoid receptor-cAMP response element-binding protein
interaction and the response of the phosphoenolpyruvate car-
boxykinase gene to glucocorticoids. J Biol Chem. 1993;268(8):
5353–5356.
55. Fo¨cking M, Ho¨lker I, Trapp T. Chronic glucocorticoid receptor
activation impairs CREB transcriptional activity in clonal neurons.
Biochem Biophys Res Commun. 2003;304(4):720–723.
1976 Doig et al 11b-HSD1 KO Augments BAT Metabolic Function Endocrinology, June 2017, 158(6):1964–1976
